Strongbridge Biopharma Plc Analysis

Strongbridge Biopharma Plc is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Strongbridge Biopharma delisted stock analysis is to determine its intrinsic value, which is an estimate of what Strongbridge Biopharma Plc is worth, separate from its market price. There are two main types of Strongbridge Biopharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Strongbridge Biopharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Strongbridge Biopharma's stock to identify patterns and trends that may indicate its future price movements.
The Strongbridge Biopharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Strongbridge Biopharma is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Strongbridge Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Strongbridge Biopharma's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Strongbridge Stock Analysis Notes

About 14.0% of the company outstanding shares are owned by corporate insiders. The book value of Strongbridge Biopharma was at this time reported as 0.83. The company recorded a loss per share of 0.72. Strongbridge Biopharma had not issued any dividends in recent years. Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs in the United States. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania. Strongbridge Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people. To find out more about Strongbridge Biopharma Plc contact the company at 610 254 9200 or learn more at http://www.strongbridgebio.com.

Strongbridge Biopharma Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Strongbridge Biopharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Strongbridge Biopharma Plc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Strongbridge Biopharma is not yet fully synchronised with the market data
Strongbridge Biopharma has some characteristics of a very speculative penny stock
Strongbridge Biopharma has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 34.72 M. Net Loss for the year was (40.16 M) with profit before overhead, payroll, taxes, and interest of 28.52 M.
Strongbridge Biopharma Plc currently holds about 63.77 M in cash with (33.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.94.
Roughly 67.0% of the company shares are owned by institutional investors

Strongbridge Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 135.54 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Strongbridge Biopharma's market, we take the total number of its shares issued and multiply it by Strongbridge Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Strongbridge Profitablity

Strongbridge Biopharma's profitability indicators refer to fundamental financial ratios that showcase Strongbridge Biopharma's ability to generate income relative to its revenue or operating costs. If, let's say, Strongbridge Biopharma is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Strongbridge Biopharma's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Strongbridge Biopharma's profitability requires more research than a typical breakdown of Strongbridge Biopharma's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (115.67) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (123.23) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $123.23.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Strongbridge Biopharma to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Pair Correlation Now

   

Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments
All  Next Launch Module
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Strongbridge Biopharma information on this page should be used as a complementary analysis to other Strongbridge Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Consideration for investing in Strongbridge Stock

If you are still planning to invest in Strongbridge Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Strongbridge Biopharma's history and understand the potential risks before investing.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stocks Directory
Find actively traded stocks across global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins